Nuvalent, Inc.
Biotechnology · Healthcare
Board Member
2022-10-04–present
Michael L. Meyers, M.D., Ph.D.
Board Member
Nuvalent, Inc.
Nuvalent, Inc.
Equibles does not estimate personal net worth.
About Michael L. Meyers, M.D., Ph.D.
Michael L. Meyers, M.D., Ph.D. is recorded as Board Member at Nuvalent, Inc. since October 4, 2022. Nuvalent, Inc. reported in an 8-K filed July 15, 2026 that Michael L. Meyers, M.D., Ph.D. resigned as director, effective July 15, 2026. Nuvalent, Inc. reported in an 8-K filed October 6, 2022 that Michael L. Meyers, M.D., Ph.D. was appointed member of the Board, effective October 4, 2022. Nuvalent, Inc. is classified in the Biotechnology industry within the Healthcare sector.
“In accordance with the Merger Agreement, at the Effective Time, each of the directors of the Company (James R. Porter, Ph.D.; Grant C. Bogle; Michael L. Meyers, M.D., Ph.D.; Christy Oliger; Anna Protopapas; Ron Squarer; Sapna Srivastava, Ph.D.; and Cameron A. Wheeler, Ph.D.) resigned from his or her respective position as a member of the Company's board of directors, and any committee thereof.”
“On October 4, 2022, in accordance with the recommendation of the Nominating and Corporate Governance Committee ("NCG Committee") of the Board of Directors (the "Board") of Nuvalent, Inc. (the "Company"), the Board elected Michael L. Meyers, M.D., Ph.D., as a member of the Board, effective immediately.”
Affiliation history
-
Nuvalent, Inc.
Board Member
SEC 8-K
Current2022-10-04–present
-
Nuvalent, Inc.
SEC 8-K
Current2022-10-04–present
-
Nuvalent, Inc.
Board Member
SEC 8-K
2022-10-04–2026-07-15